BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34321100)

  • 21. Impact of Tumor Purity on Immune Gene Expression and Clustering Analyses across Multiple Cancer Types.
    Rhee JK; Jung YC; Kim KR; Yoo J; Kim J; Lee YJ; Ko YH; Lee HH; Cho BC; Kim TM
    Cancer Immunol Res; 2018 Jan; 6(1):87-97. PubMed ID: 29141981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
    Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
    Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
    [No Abstract]   [Full Text] [Related]  

  • 23. Codon Usage Optimization in the Prokaryotic Tree of Life: How Synonymous Codons Are Differentially Selected in Sequence Domains with Different Expression Levels and Degrees of Conservation.
    López JL; Lozano MJ; Fabre ML; Lagares A
    mBio; 2020 Jul; 11(4):. PubMed ID: 32694138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients.
    Hu B; Yang XB; Sang XT
    Int Immunopharmacol; 2021 Jan; 90():107164. PubMed ID: 33172741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Implications of Aberrant PD-1 and CTLA4 Expression for Cancer Immunity and Prognosis: A Pan-Cancer Study.
    Liu JN; Kong XS; Huang T; Wang R; Li W; Chen QF
    Front Immunol; 2020; 11():2048. PubMed ID: 33072070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Codon usage patterns of LT-Ag genes in polyomaviruses from different host species.
    Cho M; Kim H; Son HS
    Virol J; 2019 Nov; 16(1):137. PubMed ID: 31727090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. tRic: a user-friendly data portal to explore the expression landscape of tRNAs in human cancers.
    Zhang Z; Ruan H; Liu CJ; Ye Y; Gong J; Diao L; Guo AY; Han L
    RNA Biol; 2020 Nov; 17(11):1674-1679. PubMed ID: 31432762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive transcriptome profiling of Taiwanese colorectal cancer implicates an ethnic basis for pathogenesis.
    Wu SM; Tsai WS; Chiang SF; Lai YH; Ma CP; Wang JH; Lin J; Lu PS; Yang CY; Tan BC; Liu H
    Sci Rep; 2020 Mar; 10(1):4526. PubMed ID: 32161294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation and selection on codon usage bias across an entire subphylum.
    LaBella AL; Opulente DA; Steenwyk JL; Hittinger CT; Rokas A
    PLoS Genet; 2019 Jul; 15(7):e1008304. PubMed ID: 31365533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Method to Identify Potential Prognostic Markers Across Distinct Tumor Types.
    Zhang B; Kochetkova E; Norberg E
    Methods Mol Biol; 2022; 2445():275-288. PubMed ID: 34972998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of differentially expressed genes between triple and non-triple-negative breast cancer using bioinformatics analysis.
    Zhai Q; Li H; Sun L; Yuan Y; Wang X
    Breast Cancer; 2019 Nov; 26(6):784-791. PubMed ID: 31197620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Codon Usage Pattern of Genes Involved in Central Nervous System.
    Uddin A; Chakraborty S
    Mol Neurobiol; 2019 Mar; 56(3):1737-1748. PubMed ID: 29922982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 35. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer.
    Wang L; Zhu H; Sun W; Liang L; Li H; Han C; Huang W; Zhao B; Peng P; Qin M; Shi L; Mo Y; Huang J
    Gene; 2022 Mar; 813():146117. PubMed ID: 34902511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling revealed MCM3 to be a better marker than Ki67 in prognosis of invasive ductal breast carcinoma patients.
    Zhao Y; Wang Y; Zhu F; Zhang J; Ma X; Zhang D
    Clin Exp Med; 2020 May; 20(2):249-259. PubMed ID: 31980982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The panoramic picture of pepsinogen gene family with pan-cancer.
    Shen S; Li H; Liu J; Sun L; Yuan Y
    Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PESSA: A web tool for pathway enrichment score-based survival analysis in cancer.
    Yang H; Shi Y; Lin A; Qi C; Liu Z; Cheng Q; Miao K; Zhang J; Luo P
    PLoS Comput Biol; 2024 May; 20(5):e1012024. PubMed ID: 38717988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of 17 mRNAs and a miRNA as an integrated prognostic signature for lung squamous cell carcinoma.
    Zhang J; Bing Z; Yan P; Tian J; Shi X; Wang Y; Yang K
    J Gene Med; 2019 Aug; 21(8):e3105. PubMed ID: 31215090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combinatorial Detection of Conserved Alteration Patterns for Identifying Cancer Subnetworks.
    Hodzic E; Shrestha R; Zhu K; Cheng K; Collins CC; Cenk Sahinalp S
    Gigascience; 2019 Apr; 8(4):. PubMed ID: 30978274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.